The American College of Physicians (ACP) recommends against prostate-specific antigen (PSA) screening for men older than age 69 and many others.
Risk of developing serious forms of urothelial carcinoma is significantly increased in smokers and leads to a higher likelihood of dying from the disease, especially for women.
A JCO study has found that Lynch syndrome carriers have an almost two-fold cumulative chance of prostate cancer at ages 60 and 80 years.
Levels of three serum proteins are much higher in kidney cancer patients, lending a highly accurate diagnosis.
Women with Lynch syndrome and endometrial cancer have elevated risks for several other cancers, including breast, bladder, and kidney cancers.
Although low-risk bladder cancer rarely escalates to muscle invasion, it is associated with an increased risk of disease-specific mortality compared with the general population.
Researchers assessed why two studies comparing prostatectomy with watchful waiting had conflicting findings in absolute mortality difference.
Therapeutic vaccines for mucosal cancers may work best when administered directly at the site of those tumors rather than elsewhere.
A posttreatment assessment of men who underwent treatment for prostate cancer revealed a side effect that has a significant impact on patients.
Men with early-stage prostate cancer may be able to inhibit tumor growth and progression by following a high-fiber diet.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|